http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2558042-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8cf778d312c2d3b6d22a65e4a3439fb7 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2560-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-50 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-88 |
| filingDate | 2011-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_594e28f5a14bd8b1511c9a0afc6a75e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd1cf1550b32836ae50b1bc3f7e65423 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fbbfea7b9feb7e8a9ab9d1264e92b81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_900008a098b71061b63db7cd7cfec6aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3189481fb76855bf40c1296fd1e315ac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8328d5f8eb212f52ceae13c638cb1dd5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06d1ea3c83ff8314e94fafc66e44a964 |
| publicationDate | 2015-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2558042-C2 |
| titleOfInvention | High-sensitivity method for measuring number of components recovered from medicinal herbs |
| abstract | FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to a high-sensitivity method for measuring the amount of individual's blood plasma glycyrrhizin, glycyrrhetinic acid and their pharmaceutically acceptable salts. The high-sensitivity method for measuring the amount of glycyrrhizin, glycyrrhetinic acid and their pharmaceutically acceptable salts is characterised by the fact that a mixture of individual's blood plasma with methanol or ammonia water in the specific concentration is introduced into a solid phase having the reverse-phase distribution function and the anion exchange function; the solid phase is then washed with a cleaning fluid that is a single-component fluid or a mixed fluid of at least two components specified in a group containing water, alkali, alcohol and acetonitrile. That is followed by elution from the solid phase in acid alcohol specified in formic acid - methanol or formic acid - ethanol; that is followed by the stage of measuring glycyrrhizin, glycyrrhetinic acid and their pharmaceutically acceptable salts by liquid chromatography - mass spectrometry or liquid chromatography - mass spectrometry/mass spectrometry. n EFFECT: high-sensitivity method enables detecting and measuring the amounts of individual's blood plasma glycyrrhizin, glycyrrhetinic acid and their pharmaceutically acceptable salts. n 4 dwg, 17 tbl, 7 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2700831-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2603363-C1 |
| priorityDate | 2010-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 73.